ES479709A1 - Procedimiento para la preparacion de corticoide-17-alcohil- carbonatos. - Google Patents

Procedimiento para la preparacion de corticoide-17-alcohil- carbonatos.

Info

Publication number
ES479709A1
ES479709A1 ES479709A ES479709A ES479709A1 ES 479709 A1 ES479709 A1 ES 479709A1 ES 479709 A ES479709 A ES 479709A ES 479709 A ES479709 A ES 479709A ES 479709 A1 ES479709 A1 ES 479709A1
Authority
ES
Spain
Prior art keywords
alkylcarbonates
corticoids
preparation
medicines against
dermatoses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES479709A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES479709A1 publication Critical patent/ES479709A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C07J71/0047—Nitrogen only at position 2(3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Corticoides de un grupo 6Alfa-flúor y/o 9Alfa-flúor y/o 11Beta-hidroxi tienen un grupo cloro orientado en una correspondiente configuración. Preferentemente, de los mencionados esteroide-21-alcohilo-aril-sulfonato-17-alcohilcarbonatos pasan a utilizarse los 17-metil-, 17- etil-, 17-n-propil, 17-n-butil, y 17-n-pentilcarbonatos así como los ésteres de ácido 21-metan-, 21-benceno, 21-tolueno, 21-para-clorobenceno, 21-para-nitrobenceno-sulfónico. De los mencionados esteroide-17,21-dialcohilortocarbonatos son preferidos los 17,21-dimetil-, 17,21-dietil-, 17,21-di-n-propil, 17,21-n-butil-, 17,21-n-pentilortocarbonatos. El intercambio nucleófilo del grupo éster de ácido 21-alcohil- o 21-aril-sulfónico, que ha de efectuarse en la primera variante del procedimiento, por un átomo de halógeno, tal como flúor, cloro, bromo o yodo, se realiza según métodos conocidos en sí.
ES479709A 1978-04-25 1979-04-19 Procedimiento para la preparacion de corticoide-17-alcohil- carbonatos. Expired ES479709A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782817988 DE2817988A1 (de) 1978-04-25 1978-04-25 Corticoid 17-alkylcarbonate und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
ES479709A1 true ES479709A1 (es) 1980-08-16

Family

ID=6037909

Family Applications (2)

Application Number Title Priority Date Filing Date
ES479709A Expired ES479709A1 (es) 1978-04-25 1979-04-19 Procedimiento para la preparacion de corticoide-17-alcohil- carbonatos.
ES488120A Expired ES488120A1 (es) 1978-04-25 1980-01-31 Procedimiento para la preparacion de corticoide-17-alcohil- carbonatos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES488120A Expired ES488120A1 (es) 1978-04-25 1980-01-31 Procedimiento para la preparacion de corticoide-17-alcohil- carbonatos

Country Status (19)

Country Link
US (1) US4377575A (es)
EP (1) EP0004975B1 (es)
JP (1) JPS54144357A (es)
AR (1) AR226157A1 (es)
AT (1) AT372094B (es)
AU (1) AU529172B2 (es)
CA (1) CA1130276A (es)
DE (2) DE2817988A1 (es)
DK (1) DK157880C (es)
ES (2) ES479709A1 (es)
FI (1) FI791307A (es)
GR (1) GR72886B (es)
HU (1) HU180788B (es)
IE (1) IE48328B1 (es)
IL (1) IL57114A (es)
NO (1) NO791365L (es)
NZ (1) NZ190256A (es)
PT (1) PT69544A (es)
ZA (1) ZA791941B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996335A (en) * 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
SE449106B (sv) * 1980-07-10 1987-04-06 Otsuka Pharma Co Ltd Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
JPS5835199A (ja) * 1981-08-26 1983-03-01 Mitsubishi Chem Ind Ltd モノヨ−ドステロイドおよびその製造法
JPS58103400A (ja) * 1981-12-11 1983-06-20 Ota Seiyaku Kk ６α−メチルプレドニゾロン誘導体
AU558725B2 (en) * 1983-09-07 1987-02-05 Mitsubishi Kasei Corporation Corticoid derivatives
JPS6056997A (ja) * 1983-09-07 1985-04-02 Mitsubishi Chem Ind Ltd 新規な６−酸素化コルチコイド／７α−カ−ボネ−ト誘導体およびその製法
DE4025342A1 (de) * 1990-08-10 1992-02-13 Hoechst Ag In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE4328819A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Corticosteroid-17-alkylcarbonat-21/0/-Carbonsäure- und Kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4333920A1 (de) 1993-10-05 1995-04-13 Hoechst Ag Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
WO2002012265A1 (en) * 2000-08-05 2002-02-14 Glaxo Group Limited 6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYL) OXY!-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
SI1383786T1 (sl) * 2001-04-30 2009-02-28 Glaxo Group Ltd Protivnetni 17.beta-karbotioatestrski derivati androstana s ciklično estrsko skupino na položaju 17.alfa
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20040138192A1 (en) * 2003-01-13 2004-07-15 Chemagis Ltd. Crystalline forms of halobetasol propionate
US7208485B2 (en) * 2003-01-13 2007-04-24 Chemagis Ltd. Crystalline forms of halobetasol propionate
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
NZ584160A (en) * 2007-10-04 2011-05-27 Astrazeneca Ab Steroidal [3,2-c] pyrazole compounds, with glucocorticoid activity
CN101945885A (zh) * 2007-12-20 2011-01-12 阿斯利康(瑞典)有限公司 用作糖皮质激素受体激动剂的甾类衍生物
UY32520A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides
UY32521A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Combinación para emplear en el tratamiento de enfermedades respiratorias
UY32523A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
UY32525A (es) * 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1253831A (en) * 1968-01-19 1971-11-17 Glaxo Lab Ltd 9alpha,21-DIHALOPREGNANE COMPOUNDS
GB1281689A (en) * 1968-10-14 1972-07-12 Glaxo Lab Ltd Steroid 21-phosphates
US3558675A (en) * 1969-06-30 1971-01-26 Merck & Co Inc Steroid carbonates and process
GB1440063A (en) * 1972-08-11 1976-06-23 Glaxo Lab Ltd 17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids
US3832366A (en) * 1973-07-30 1974-08-27 Squibb & Sons Inc Process for preparing 21-chloro-17-acyloxy-20-ketosteroids
YU54476A (en) * 1975-03-31 1982-05-31 Taisho Pharmaceutical Co Ltd Process for obtaining 17-ester 21-halo-pregnane
US4021459A (en) * 1975-08-14 1977-05-03 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy 20-keto-pregnenes
DE2735110A1 (de) * 1977-08-04 1979-02-15 Hoechst Ag Corticoid-17-alkylcarbonate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
AR226157A1 (es) 1982-06-15
ATA307479A (de) 1983-01-15
IE790831L (en) 1979-10-25
GR72886B (es) 1984-01-02
DE2817988A1 (de) 1979-11-08
JPS54144357A (en) 1979-11-10
NO791365L (no) 1979-10-26
IE48328B1 (en) 1984-12-12
AT372094B (de) 1983-08-25
DK157880B (da) 1990-02-26
AU529172B2 (en) 1983-05-26
EP0004975A3 (en) 1979-11-14
NZ190256A (en) 1981-03-16
EP0004975A2 (de) 1979-10-31
ES488120A1 (es) 1980-09-16
US4377575A (en) 1983-03-22
JPS6252759B2 (es) 1987-11-06
IL57114A0 (en) 1979-07-25
DE2962122D1 (en) 1982-03-25
HU180788B (en) 1983-04-29
DK157880C (da) 1990-07-30
IL57114A (en) 1983-11-30
EP0004975B1 (de) 1982-02-17
FI791307A (fi) 1979-10-26
ZA791941B (en) 1980-04-30
CA1130276A (en) 1982-08-24
DK168579A (da) 1979-10-26
PT69544A (de) 1979-05-01

Similar Documents

Publication Publication Date Title
ES488120A1 (es) Procedimiento para la preparacion de corticoide-17-alcohil- carbonatos
ES472147A1 (es) Procedimiento para la preparacion de nuevos esteroido-17- alcohilcarbonatos.
DE2960222D1 (en) Phenoxyalkylcarboxylic-acid derivatives, process for their preparation and medicaments containing them
PH14287A (en) Naphthyridine derivatives,pharmaceutical compositions containing same and method of treatment thereof
AU4376479A (en) Continuous method for production of ethanol
ZA791276B (en) N-oxacyclic-alkylpiperidyl-diazacompounds,process for their manufacture and pharmaceutical compositions containing them
DE2961983D1 (en) Pyrrolidine-2-methanol derivatives, process for their preparation and medicaments containing them
PH16138A (en) Process for the preparation of 6-alpha-halo-substituted-pregna-4-ene-3 ones and pregna-1,4-diene-3-ones
GB1553424A (en) Method of treating protozal diseases
AU514983B2 (en) Termentation process for production of xanthan
DE2963947D1 (en) Process for the manufacture of sodium amoxicillin preparations
ZA79271B (en) 1-naphthyl-acetic acid derivatives,process for their preparation and their therapeutic applications
DE2962169D1 (en) Chromanon derivatives, process for their preparation, and their use as medicines and growth-promoting agents
DE2962886D1 (en) Derivatives of l-cysteine, their use as medicaments and process for their preparation
ZA802011B (en) New prostaglandin derivatives in the 6-keto-pge1 series
DE2961524D1 (en) Glycofuranosyl-nitrosourea derivatives, process for their manufacture and their pharmaceutical preparations
SU1178325A3 (ru) "cпocoб пoлучehия пpoизboдhыx 2,2-диaлkил-18,19-диhopпpeгh-4-eh-3,20-диoha"
HK58085A (en) Novel azathianaphthalene derivatives,process for their manufacture,pharmaceutical preparations containing them and their use
DE2861128D1 (en) Esters of n-pyrimidinyl-carboximidic acid, process for their preparation and medicines containing them.
DE2960069D1 (en) Process for the manufacture of n,n-dimethylaminoacetonitrile
AU513409B2 (en) Preparations of 3-N-pyrrolidino-4-phenoxy-5 sulfamylbenzoic acid and process for their manufacture
DE2961424D1 (en) Process for the production of 2-substituted 1-alkyl-nitroimidazoles
ZA793991B (en) Novel prostaglandin derivatives of the delta 2-11-desoxy-pgf2 or pge2 series,process for their manufacture and their use as medicaments
FR2341313A1 (fr) Nouvelles quinoleines substituees, leur procede de preparation et leur application comme medicament
JPS5246254A (en) Joint manufacturing process

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970505